Clinical reference Biomarker Directory
Back to directory

Glucagon

Established

Glucagon excess is the hallmark of glucagonoma; the hormone is also used therapeutically for severe hypoglycemia.

Also known as Glucagon
In plain language

Glucagon raises blood sugar and works opposite to insulin. A rare tumor that makes too much of it causes a distinctive rash, diabetes, and weight loss. Glucagon is also given as an emergency treatment when someone's blood sugar drops dangerously low.

Biomarker & context

Glucagon is a pancreatic alpha-cell hormone that raises blood glucose by stimulating liver glycogen breakdown, functioning as insulin's counter-regulatory partner.

What it indicates

Markedly elevated glucagon is the hallmark of glucagonoma, a rare pancreatic neuroendocrine tumor causing a distinctive skin rash (necrolytic migratory erythema), diabetes, and weight loss; low or blunted glucagon response is assessed in the hypoglycemia workup.

Diagnosis & clinical testing

Measured via serum immunoassay; glucagonoma diagnosis combines markedly elevated fasting glucagon (often >500-1000 pg/mL) with imaging localization of the pancreatic tumor.

Guiding treatment

Glucagonoma is treated with surgical resection when possible, plus somatostatin analogs for symptom control; glucagon itself is also used therapeutically as an emergency treatment for severe hypoglycemia.

Clinical significance

Diagnostic marker for a rare, distinctive neuroendocrine tumor syndrome.

References
  1. General endocrinology and oncology reference literature on glucagonoma diagnosis and management.